Certara is a leader in Model-Informed Drug Development (MIDD), offering essential software and services that reduce drug development costs and time. The company's diversified software portfolio and ...
ペンシルベニア州ラドナー：2024年10月2日 - モデリング＆シミュレーションを強みとするサターラ（Nasdaq: CERT）は、本日Chemaxon (ケムアクソン)社の買収完了を発表しました。 Chemaxonは、ライフ ...
ライフサイエンス企業にバイオシミュレーション予測と科学情報テクノロジーを提供し、創薬から商業化における確実な意思決定を支援します。 ペンシルベニア州ラドナー：2024年10月2日 ...
Die kombinierte Organisation bietet Life-Sciences-Unternehmen prädiktive Biosimulations- und wissenschaftliche Informatikfunktionen und verbessert so die Sicherheit bei der Entscheidungsfindung von ...
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
RADNOR, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has completed the acquisition of Chemaxon. Chemaxon ...
Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has completed the acquisition of Chemaxon. Chemaxon develops leading scientific informatics ...
Certara, Inc., a global leader in model-informed drug development, announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results